# Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study

> **NCT02756468** · — · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 100 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **OTHER:** pts operated for pancreatic cancer

## Key facts

- **NCT ID:** NCT02756468
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02756468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02756468, "Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT02756468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*